Measuring strain key to detecting CV damage by chemotherapy
How sick children could save their family members
How sick children could save their family members
Applying a cancer model as therapy for heart failure
“We are in uncharted territory”
At intersection of heart failure and type 2 diabetes
A keynote address at our Scientific Symposium explores a critical area
An eye towards quality improvement
Providing the best possible care to patients and families
Enhanced MRI tracks stem cells’ effectiveness
Overcoming a roadblock in cardiac regeneration research
Targeting non-invasive treatment for cardiac amyloidosis
Targeting non-invasive solution to treating cardiac amyloidosis
How hospitals can address heart failure burden
Dr. Adrian Hernandez: blend systems of care with systems of research
Uncovering macrophages that repair the heart
Protecting the heart from its own immune system post-MI
Pioneering use of CRISPR for upregulation of utrophin
Ground-breaking work underway using CRISPR
Using ExAC to reassess the pathogenicity of Mendelian disease genes in cardiomyopathy
ExAC used to reassess pathogenicity of Mendelian disease
